GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Clover Corp Ltd (ASX:CLV) » Definitions » COGS-to-Revenue

Clover (ASX:CLV) COGS-to-Revenue : 0.73 (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Clover COGS-to-Revenue?

Clover's Cost of Goods Sold for the six months ended in Jan. 2024 was A$19.96 Mil. Its Revenue for the six months ended in Jan. 2024 was A$27.32 Mil.

Clover's COGS to Revenue for the six months ended in Jan. 2024 was 0.73.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Clover's Gross Margin % for the six months ended in Jan. 2024 was 26.95%.


Clover COGS-to-Revenue Historical Data

The historical data trend for Clover's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover COGS-to-Revenue Chart

Clover Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.66 0.70 0.70 0.70

Clover Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.70 0.69 0.72 0.73

Clover COGS-to-Revenue Calculation

Clover's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=56.137 / 79.875
=0.70

Clover's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=19.959 / 27.321
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clover  (ASX:CLV) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Clover's Gross Margin % for the six months ended in Jan. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 19.959 / 27.321
=26.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Clover COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Clover's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover (ASX:CLV) Business Description

Traded in Other Exchanges
N/A
Address
39 Pinnacle Road, Altona North, Melbourne, VIC, AUS, 3025
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe, and the Americas. Majority of the revenue is derived from Asia.